Should Slow Vital Capacity Replace Forced Vital Capacity in IPF? - Amsterdam 2025

Clinical aspects in interstitial lung disease

Chair(s): Dominique Israel-Biet, Gautam George

Session type: Poster session

Should Slow Vital Capacity Replace Forced Vital Capacity in IPF?

Fatma Arslan

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Gender differences in idiopathic pulmonary fibrosis (IPF) from the British Thoracic Society (BTS) UK ILD registry.

Leng Cheng Sia

Poster

Abstract

Breathing effort evaluation and monitoring through nasal manometry in fibrosing interstitial lung disease (F-ILDs) with usual interstitial pneumonia (UIP) pattern: preliminary analysis from a prospective observational monocentric study

Athina Patsoura

Poster

Abstract

Twelve month experience of a structured interstitial lung abnormality (ILA) pathway: insights and outcomes

Trishala Raj

Poster

Abstract

Identification of UIP pattern fibrosis progression after antifibrotic therapy

Gage Willox

Poster

Abstract

Effect of pulmonary rehabilitation on exercise tolerance in patients with interstitial lung disease

Houda Snène

Poster

Abstract

Gender-related features of interstitial lung diseases: an unsupervised machine learning approach

Esterina Boniello

Poster

Abstract

Impact of Discrepancies Between BAL and TBLC Findings on ILD Treatment Strategies: A Retrospective Study with Insights into Cytology Variability

Koji Kuronuma

Poster

Abstract

Geriatric nutrition risk index as an indicator of acute exacerbation and mortality risk in patients with idiopathic pulmonary fibrosis

Ismail Hanta

Poster

Abstract

SERUM TRYPSIN-LIKE ACTIVITY (TPA) IN PATIENTS (PTS) WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)

Valeriia Dmytrychenko

Poster

Abstract

Content Validity of AI-Generated Medical Information on Idiopathic Pulmonary Fibrosis (IPF): A Comparative Analysis of ChatGPT-4 and Gemini 1.5 Pro

Ivan Cherrez-ojeda

Poster

Abstract

Applying a pre-fight algorithm in Interstitial lung disease

Lucy Robertson

Poster

Abstract

Comparison of the baseline clinical and HRCT characteristics of Insilicos ISM001_055 phase 2a trial cohort in China with real-world IPF datasets

Kiril R. Kirov

Poster

Abstract

Comparison of IPF patients using pirfenidone and nintedanib:Real-life data

Fatma Demirci Üçsular

Poster

Abstract

Disease course towards the end of life in patients with pulmonary fibrosis.

François Lestelle

Poster

Abstract

Should Slow Vital Capacity Replace Forced Vital Capacity in IPF?

Fatma Arslan

Poster

Abstract

Characterization of Unclassifiable ILD: Subclassification and Clinical Features from the PROMISE Study in Japan

Takashi Ogura

Poster

Abstract

The clinical and economic impact of time to diagnosis in patients with progressive fibrosing interstitial lung disease: a systematic review

Zhongyi Deng

Poster

Abstract

Baseline characteristics of patients in the real-world INCHANGE study in patients with progressive pulmonary fibrosis (PPF)

Claudia Lucia Toma

Poster

Abstract

The role of social deprivation in post-admission interstitial lung disease all-cause mortality

Laura White

Poster

Abstract

Real-life experience of access to antifibrotics for patients with IPF: a single-center observational study

Maham Adil

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}